Andrew Faughnan | Associate Director, Investor Relations |
John Crowley | Chairman and Chief Executive Officer |
Bradley Campbell | President and Chief Operating Officer |
Chip Baird | Chief Financial Officer |
Jay Barth | Chief Medical Officer |
Hung Do | Chief Science Officer |
Jeff Castelli | Chief Portfolio Officer |
Anupam Rama | JPMorgan |
Ritu Baral | Cowen |
Tazeen Ahmad | BOA |
Joseph Schwartz | Leerink Partners |
Mike Ulz | Baird |
Good day, ladies and gentlemen, and welcome to the Amicus Therapeutics Second Quarter 2018 Results Conference Call and Webcast.
As a reminder, today's conference call is being recorded I would now like to turn the call over to Mr. Andrew Faughnan, Associate Director, Investor Relations. Sir, you may begin.
Thank you, Styler [ph].